Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Saokim Pharma, officially known as Sao Kim Pharmaceutical Joint Stock Company, is a prominent Vietnamese pharmaceutical manufacturer specializing in anti-malarial treatments. Founded in 1999 and headquartered in Hanoi, the company has established itself as one of the world's largest producers and exporters of Artemisinin and its semi-synthetic derivatives. Their product portfolio includes high-quality active pharmaceutical ingredients (APIs) such as Artesunate, Artemether, and Dihydroartemisinin, as well as finished dosage forms. The company operates WHO-GMP certified manufacturing facilities and maintains a strong export presence across Asia, Africa, and Europe. Saokim Pharma plays a critical role in the global supply chain for malaria therapy, collaborating with international health organizations to combat the disease. In addition to its anti-malarial focus, the company provides contract manufacturing services and produces various generic medicines for the domestic market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Saokim Pharma.